Research Blends
TrustScore 4.8
Shipped in POWDER FORM and requires reconstitution using our reconstitution solution.
Size
$180.00
$145.00
✓ In stock
Quantity
Bundle & Save
Damaged, incorrect, or below our published purity standards? Replaced or refunded — no questions asked.
Best Sellers
Fast UPS Shipping
Free 3-Day Select over $250
60-Day Money-Back
Guarantee
Secure Checkout
256-bit SSL
GLOW is a proprietary research blend combining GLP-receptor agonist compound(s) with AOD-9604, the lipolytic hGH fragment. The combination targets both incretin-driven metabolic signaling and direct adipose tissue fat mobilization pathways, studied as a complementary metabolic research tool.
The GLP component activates incretin receptors to modulate glucose homeostasis and appetite regulation. AOD-9604 provides direct lipolytic signaling in adipose tissue via beta-3 adrenergic receptor activation and inhibits lipogenesis. Together the compounds engage distinct but complementary pathways in metabolic research.
Research includes combined incretin + lipolytic metabolic models, body composition studies, comparative analysis vs. single-compound formulations, adipose tissue biology, and metabolic disease research.
Research Blends
| Property | GLOW | KLOW | AOD-9604 | GLP-1SG |
|---|---|---|---|---|
| Type | Research Blend — GLP + AOD | Research Blend — GLP + AOD | Modified hGH Fragment (176–191) | GLP-1 Receptor Agonist |
| Molecular Weight | Variable (blend) | Variable (blend) | 1,815.08 g/mol | 4,113.58 g/mol |
| Amino Acids | — | — | 16 | 31 |
| CAS Number | N/A — Research Blend | N/A — Research Blend | 221231-10-3 | 910463-68-2 |
| Formula | Blend | Blend | C₇₈H₁₂₃N₂₃O₂₃S₂ | C₁₈₇H₂₉₁N₄₅O₅₉ |
| CURRENT | View Product → | View Product → | View Product → |
Research Use Only. All products sold exclusively for in vitro and qualified laboratory research. Not FDA-approved and not for human or animal consumption.
Your cart is empty
Add some peptides to get started
